DrugInfoSys

Dacarbazine

Drug #210

Dacarbazine is an antineoplastic drug. Dacarbazine is a synthetic compound that functions as an alkylating agent. All alkylating agents have or can form an alkyl group that becomes covalently bound to cellular constituents. Dacarbazine is effective in the treatment of different cancers to slow or stop the growth of abnormal or cancerous cells. Dacarbazine is used in combination with different anticancerous drugs to obtain excellent therapeutic effects and to minimize unwanted effects or toxicities.

Primary Characteristics

It is of Synthetic origin and belongs to Triazeno Imidazole.

It belongs to Alkylating Agents pharmacological group on the basis of mechanism of action and also classified in Antineoplastic Agent, Alkylating Agent pharmacological group.

Molecular Weight: 182.2 · pKa: 4.4 · Solubility in Water: > 1 in 1000 · Solubility in Alcohol: > 1 in 1000 · Non-proprietary name: Dacarbazine.

Molecular structure of Dacarbazine

Pharmacokinetics

Distribution: Dacarbazine has a plasma protein binding is 5%.

Elimination: it is metabolised via Hepatic, plasma half-life is 5 hr, renal excretion is < 50%.

Advertisement

Indications

Contraindications

None recorded.

Dosage

Dacarbazine's dosage details are as follows:

DoseSingle DoseFrequencyRouteInstructions
Adult Dosage
3.25 mg/kg3.25 mg/kgEvery 24hIV For 10 Days, repeated per month
Paediatric Dosage (20kg)
No data.
Neonatal Dosage (3kg)
No data.

Drug Interactions

Unknown1 interaction

Always consult your physician for the change of dose regimen or an alternative drug of choice that may strictly be required.

Side Effects

Dacarbazine in overdosage may give rise to further complications which include Photosensitivity .

Dacarbazine produces potentially life-threatening effects which include Hepatotoxicity , Moderate myelosuppression. Careful monitoring is needed with proper medical management.

The signs and symptoms that are produced after acute overdosage of Dacarbazine are Severe myelosuppression.

Dacarbazine is known to cause more or less tolerable side effects which are usually transient. These include Alopecia, Diarrhea, Facial flushing, Facial paresthesia, Fever, Malaise, Myalgia, Nausea, Vomiting .

Warnings / Precautions

Dacarbazine should be used with caution in patients with pre-existing blood disorders, liver disease or kidney disease, dental disease. It is classified as pregnancy category C and not recommended for use in pregnancy or lactation.

Available Brands

Click on a strength to view available brands.

Single Ingredient

Multi-Ingredient Combinations

Storage Conditions

Dacarbazine should be stored Inj (reconstituted soln).

Drug Classification

  1. 1.8.2Cytotoxic (anti-neoplastic) drugs

Manufacturers

Manufacturers of Dacarbazine in Pakistan: